Due to debt repayement of
-37.29% Recursion Pharmaceuticals Inc improved Total Debt to Equity in forth quarter 2023 to
0, a new company low.
Within
Biotechnology & Pharmaceuticals industry Recursion Pharmaceuticals Inc achieved the lowest Total Debt to Equity in the forth quarter 2023. While Total Debt to Equity total ranking has improved so far in the forth quarter 2023 to
23, from total ranking in the third quarter 2023 at
54 .
Explain Debt to Equity Ratio?
What is the structure of RXRX´s Total Debt?
How valuable is the RXRX´s Equity?